Target-based Classification of Drugs

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

     Remark
 G Protein-coupled receptors
 
 Cytokine receptors
   Class I cytokine receptors (hematopoietin family receptors)
   Class II cytokine receptors (interferon/IL-10 family receptors)
   Receptor tyrosine kinase
     RTK class I (EGF receptor family)
       EGFR tyrosine kinase [HSA:1956] [KO:K04361]
         Cetuximab [ATC:L01XC06]
         Panitumumab [ATC:L01XC08]
         Gefitinib [ATC:L01XE02]
         Erlotinib [ATC:L01XE03]
           D07907  Erlotinib (INN)
           D04023  Erlotinib hydrochloride (JAN/USAN)
Inhibitor
Inhibitor
         Lapatinib [ATC:L01XE07]
         Vandetanib [ATC:L01XE12]
         Afatinib [ATC:L01XE13]
         Canertinib
         Imgatuzumab
         Necitumumab
         Neratinib
         Pelitinib
         Varlitinib
         Zalutumumab
       ERBB2 tyrosine kinase [HSA:2064] [KO:K05083]
       ERBB3 tyrosine kinase [HSA:2065] [KO:K05084]
       ERBB4 tyrosine kinase [HSA:2066] [KO:K05085]
     RTK class II (Insulin receptor family)
     RTK class III (PDGF receptor family)
     RTK class IV (FGF receptor family)
     RTK class V (VEGF receptor family)
     RTK class VI (HGF receptor family)
     RTK class VIII (EPH receptor family)
     RTK class X (LTK receptor family)
     RTK class XIV (RET receptor family)
   TNF receptor family
   IL-1 receptor family
   IL-17 receptor family
   TGF-beta receptors
   Chemokine receptors
 
 Nuclear receptors
 
 Ion channels
 
 Transporters
 
 Enzymes
 
 Protein kinases
 
 Cytokines
 
 Others

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 28, 2014

» Japanese version